株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液透析装置:パイプライン分析

Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 336434
出版日 ページ情報 英文 180 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
血液透析装置:パイプライン分析 Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2017
出版日: 2017年08月04日 ページ情報: 英文 180 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の血液透析装置のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 血液透析装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 血液透析装置:開発中のパイプライン製品 (企業別)

  • 血液透析装置の開発企業:パイプライン製品 (開発段階別)
  • 血液透析装置:開発段階別のパイプライン製品の一覧

第5章 血液透析装置の開発企業・製品の概要

  • Bioconnect Systems, Inc.
    • パイプライン製品および進行中の治験の概要
  • Blood Purification Technologies, Inc.
  • Clil Medical
  • ExThera Medical LLC.
  • Hemova Medical
  • Katharos, Inc.
  • Medtronic plc
  • Outset Medical, Inc.
  • Phraxis, Inc.

第6章 血液透析装置:昨今の市場動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0407EPD

GlobalData's Medical Devices sector report, "Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Hemodialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemodialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemodialysis Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemodialysis Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemodialysis Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Hemodialysis Equipment Overview 9

3 Products under Development 10

  • 3.1 Hemodialysis Equipment - Pipeline Products by Stage of Development 10
  • 3.2 Hemodialysis Equipment - Pipeline Products by Segment 11
  • 3.3 Hemodialysis Equipment - Pipeline Products by Territory 12
  • 3.4 Hemodialysis Equipment - Pipeline Products by Regulatory Path 13
  • 3.5 Hemodialysis Equipment - Pipeline Products by Estimated Approval Date 14
  • 3.6 Hemodialysis Equipment - Ongoing Clinical Trials 15

4 Hemodialysis Equipment - Pipeline Products under Development by Companies 16

  • 4.1 Hemodialysis Equipment Companies - Pipeline Products by Stage of Development 16
  • 4.2 Hemodialysis Equipment - Pipeline Products by Stage of Development 17

5 Hemodialysis Equipment Companies and Product Overview 18

  • 5.1 Access for Life Ltd Company Overview 18
    • 5.1.1 Access for Life Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Alteco Medical AB Company Overview 19
    • 5.2.1 Alteco Medical AB Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 AngioDynamics Inc Company Overview 20
    • 5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Asahi Kasei Corp Company Overview 21
    • 5.4.1 Asahi Kasei Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.5 Baxter Healthcare Corp Company Overview 22
    • 5.5.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.6 Baxter International Inc Company Overview 26
    • 5.6.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.7 Bioconnect Systems Inc Company Overview 27
    • 5.7.1 Bioconnect Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.8 Clil Medical Company Overview 28
    • 5.8.1 Clil Medical Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.9 Columbia University Company Overview 29
    • 5.9.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.10 Eqalix Inc Company Overview 30
    • 5.10.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 ExThera Medical Corporation Company Overview 31
    • 5.11.1 ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.12 Fresenius Medical Care AG & Co KGaA Company Overview 34
    • 5.12.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Georgia Institute of Technology Company Overview 35
    • 5.13.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.14 Hemova Medical Company Overview 36
    • 5.14.1 Hemova Medical Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.15 Katharos, Inc. Company Overview 37
    • 5.15.1 Katharos, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.16 Merit Medical Systems, Inc. Company Overview 38
    • 5.16.1 Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.17 Nephros Inc Company Overview 40
    • 5.17.1 Nephros Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.18 Occlutech International AB Company Overview 43
    • 5.18.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 Outset Medical, Inc. Company Overview 44
    • 5.19.1 Outset Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 Oxford Biomaterials Ltd Company Overview 47
    • 5.20.1 Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.21 Phraxis, Inc. Company Overview 48
    • 5.21.1 Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.22 Stent Tek Ltd Company Overview 49
    • 5.22.1 Stent Tek Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.23 Xerem Medical Ltd Company Overview 50
    • 5.23.1 Xerem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

6 Hemodialysis Equipment- Recent Developments 51

  • 6.1 Aug 01, 2017: Fresenius Medical Care delivers another quarter of strong revenue growth 51
  • 6.2 Aug 01, 2017: DaVita Reports 2nd Quarter 2017 Results 53
  • 6.3 Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 55
  • 6.4 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 57
  • 6.5 Jul 31, 2017: Mesa Labs Reports Record First Quarter Revenues 57
  • 6.6 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 59
  • 6.7 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 61
  • 6.8 Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 62
  • 6.9 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 62
  • 6.10 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 64
  • 6.11 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 64
  • 6.12 Jul 10, 2017: Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance 65
  • 6.13 Jun 29, 2017: DaVita Medical Group Recognized for Excellence in Coordinated Care 66
  • 6.14 Jun 29, 2017: Bernhard Kernen named CFO of Raumedic 67
  • 6.15 Jun 28, 2017: Aethlon Medical Announces Fiscal 2017 Results 67
  • 6.16 Jun 08, 2017: Cantel Medical Reports Financial Results For The Third Quarter Ended April 30, 2017 69
  • 6.17 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 70
  • 6.18 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 71
  • 6.19 Jun 07, 2017: Mesa Labs Reports Record Net Income and Adjusted Net Income 71
  • 6.20 Jun 05, 2017: New Data Demonstrates High Performance of HDx Enabled by THERANOVA, Baxter's Novel Hemodialysis Therapy 73
  • 6.21 May 26, 2017: Merit Medical Announces Appointment of New Director 74
  • 6.22 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 74
  • 6.23 May 24, 2017: DaVita Kidney Care Welcomes Eric Severson as Chief People Officer 77
  • 6.24 May 18, 2017: Dr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team 78
  • 6.25 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 78
  • 6.26 May 09, 2017: Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update 79
  • 6.27 May 09, 2017: NxStage Reports First Quarter Financial Results 80
  • 6.28 May 03, 2017: Fresenius Medical Care delivers strong first quarter 2017 81
  • 6.29 May 02, 2017: DaVita Reports 1st Quarter 2017 Results 83
  • 6.30 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 85
  • 6.31 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 86
  • 6.32 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 87
  • 6.33 Apr 24, 2017: Aethlon Medical Releases Shareholder Update 89
  • 6.34 Apr 23, 2017: Bard Announces First Quarter Results 90
  • 6.35 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 91
  • 6.36 Apr 10, 2017: DaVita Names New President of International 91
  • 6.37 Mar 31, 2017: B. Braun continues its sales and earnings growth 92
  • 6.38 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 93
  • 6.39 Mar 22, 2017: Outset Medical Announces Appointment of Gus Castello as Chief Operating Officer 95
  • 6.40 Mar 20, 2017: Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 96
  • 6.41 Mar 09, 2017: Cantel Medical Reports Financial Results For The Second Quarter Ended January 31, 2017 97
  • 6.42 Mar 08, 2017: DaVita Kidney Care Welcomes Dr. Francesca Tentori to Physician Leadership Team 98
  • 6.43 Mar 06, 2017: Nephros Receives FDA 510(k) Clearance Of EndoPur Endotoxin 10" Filter 98
  • 6.44 Mar 01, 2017: Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes 99
  • 6.45 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 99
  • 6.46 Feb 28, 2017: Dr. Adam Weinstein Joins DaVita Kidney Care Physician Leadership Team 100
  • 6.47 Feb 28, 2017: NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results 100
  • 6.48 Feb 23, 2017: DaVita Appoints Chief Medical Officer for Integrated Kidney Care 101
  • 6.49 Feb 22, 2017: Fresenius Medical Care delivers strong 2016 results and sets ambitious growth targets for 2017 102
  • 6.50 Feb 22, 2017: Change in the B. Braun Management Board 106
  • 6.51 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 106
  • 6.52 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 109
  • 6.53 Feb 16, 2017: DaVita 4th Quarter 2016 Results 110
  • 6.54 Feb 14, 2017: Nephros Announces Appointment of Andrew Astor as Chief Financial Officer 112
  • 6.55 Feb 10, 2017: Aethlon Medical Announces Fiscal 2017 Third Quarter Results 112
  • 6.56 Feb 09, 2017: Terumo Announces Change of Executive Officers 114
  • 6.57 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 115
  • 6.58 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 115
  • 6.59 Feb 06, 2017: Quanta Appoints World Leading Nephrologist to Medical Advisory Board 116
  • 6.60 Feb 03, 2017: NxStage Announces Appointment of Chief Medical Officer 116
  • 6.61 Feb 02, 2017: Mesa Labs Reports Record Third Quarter Revenues and Adjusted Net Income 117
  • 6.62 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 118
  • 6.63 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 121
  • 6.64 Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 122
  • 6.65 Jan 31, 2017: Terumo Opens a Branch in Yangon 123
  • 6.66 Jan 26, 2017: U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation 123
  • 6.67 Jan 26, 2017: Bard Announces Fourth Quarter Results 123
  • 6.68 Jan 24, 2017: Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance 124
  • 6.69 Jan 13, 2017: Statement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order 125
  • 6.70 Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 126
  • 6.71 Jan 11, 2017: Aethlon Medical Provides Clinical Study Update and a Review of 2016 Accomplishments 127
  • 6.72 Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 128
  • 6.73 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 128
  • 6.74 Jan 05, 2017: DaVita Announces Joel Ackerman to be CFO 130
  • 6.75 Jan 05, 2017: DaVita Appoints Pascal Desroches to Board of Directors 130
  • 6.76 Jan 03, 2017: Cantel Medical Appoints Dottie Donnelly Brienza as Senior Vice President and Chief Human Resources Officer 131
  • 6.77 Dec 21, 2016: "DaVita Way of Giving" Donates Record-breaking $2.2 Million to Local Charities 132
  • 6.78 Dec 14, 2016: US Food & Drug Administration 510(k) Clearance for Pall-Aquasafe Disposable Water Filters 132
  • 6.79 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 133
  • 6.80 Dec 08, 2016: Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2016 134
  • 6.81 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 134
  • 6.82 Dec 02, 2016: Change in Investor Relations Management - Dr. Dominik Heger joins Fresenius Medical Care 136
  • 6.83 Dec 01, 2016: Fresenius Medical Care will focus on IFRS reporting and discontinue U.S. GAAP financial statements 137
  • 6.84 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 137
  • 6.85 Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden 140
  • 6.86 Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 140
  • 6.87 Nov 17, 2016: Fresenius Medical Care Showcases Breadth and Depth of Clinical Research with Nearly 70 Abstracts Slated for Presentation at the American Society of Nephrology 2016 Kidney Week Meeting 141
  • 6.88 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 143
  • 6.89 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 143
  • 6.90 Nov 10, 2016: Aethlon Medical Announces Fiscal 2017 Second Quarter Results 144
  • 6.91 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 145
  • 6.92 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 146
  • 6.93 Nov 03, 2016: NxStage Reports Third Quarter Financial Results; Raises Full-Year Revenue Guidance And Cuts Net Loss Guidance In Half 147
  • 6.94 Nov 02, 2016: DaVita 3rd Quarter 2016 Results 148
  • 6.95 Nov 02, 2016: Mesa Labs Reports Record Second Quarter Revenues and Adjusted Net Income 150
  • 6.96 Oct 27, 2016: Fresenius Medical Care reports strong third quarter and confirms full year guidance 151
  • 6.97 Oct 27, 2016: Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised 154
  • 6.98 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 158
  • 6.99 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 159
  • 6.100 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 160
  • 6.101 Oct 25, 2016: Bard Announces Third Quarter Results 162
  • 6.102 Oct 24, 2016: Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments 163
  • 6.103 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 164
  • 6.104 Sep 29, 2016: Cantel Medical Reports Record Results for the Fourth Quarter Ended July 31, 2016 165
  • 6.105 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 166
  • 6.106 Sep 14, 2016: DaVita Names New President for Florida Medical Group Operations 167
  • 6.107 Sep 01, 2016: Cantel Medical Promotes Seth M. Yellin to Executive Vice President 167
  • 6.108 Aug 30, 2016: The Everett Clinic Announces Leadership Transitions 167
  • 6.109 Aug 30, 2016: DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team 168
  • 6.110 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 168
  • 6.111 Aug 23, 2016: DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team 171
  • 6.112 Aug 17, 2016: DaVita Hospital Services Receives Re-Accreditation from The Joint Commission 172
  • 6.113 Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago 172
  • 6.114 Aug 11, 2016: Aethlon Medical Announces Fiscal 2017 First Quarter Results 173
  • 6.115 Aug 08, 2016: DaVita HealthCare Partners 2nd Quarter 2016 Results 173
  • 6.116 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 176

7 Appendix 177

  • 7.1 Methodology 177
  • 7.2 About GlobalData 180
  • 7.3 Contact Us 180
  • 7.4 Disclaimer 180

List of Tables

1.1 List of Tables

  • Table 1: Hemodialysis Equipment - Pipeline Products by Stage of Development 10
  • Table 2: Hemodialysis Equipment - Pipeline Products by Segment 11
  • Table 3: Hemodialysis Equipment - Pipeline Products by Territory 12
  • Table 4: Hemodialysis Equipment - Pipeline Products by Regulatory Path 13
  • Table 5: Hemodialysis Equipment - Pipeline Products by Estimated Approval Date 14
  • Table 6: Hemodialysis Equipment - Ongoing Clinical Trials 15
  • Table 7: Hemodialysis Equipment Companies - Pipeline Products by Stage of Development 16
  • Table 8: Hemodialysis Equipment - Pipeline Products by Stage of Development 17
  • Table 9: Access for Life Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 10: JEM Device - Hemodialysis - Product Status 18
  • Table 11: JEM Device - Hemodialysis - Product Description 18
  • Table 12: Alteco Medical AB Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 13: Alteco LPS Adsorber - Product Status 19
  • Table 14: Alteco LPS Adsorber - Product Description 19
  • Table 15: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 16: Next Generation Dialysis Device - Product Status 20
  • Table 17: Next Generation Dialysis Device - Product Description 20
  • Table 18: Asahi Kasei Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 19: Hemodialysis Equipment - Product Status 21
  • Table 20: Hemodialysis Equipment - Product Description 21
  • Table 21: Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 22: HDx Enabled By THERANOVA - Product Status 22
  • Table 23: HDx Enabled By THERANOVA - Product Description 22
  • Table 24: THERANOVA Dialyser - Product Status 23
  • Table 25: THERANOVA Dialyser - Product Description 23
  • Table 26: Baxter Healthcare Corp - Ongoing Clinical Trials Overview 24
  • Table 27: THERANOVA Dialyser - Characterization of Proteins and Forms of Albumin Removal Capacities of the Theranova Membrane by Innovating Proteomic Investigations 25
  • Table 28: THERANOVA Dialyser - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification 25
  • Table 29: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 30: Next Gen ICHD Monitor - Product Status 26
  • Table 31: Next Gen ICHD Monitor - Product Description 26
  • Table 32: Bioconnect Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 33: Optiflow Vascular Anastomotic System - Product Status 27
  • Table 34: Optiflow Vascular Anastomotic System - Product Description 27
  • Table 35: Clil Medical Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 36: Implantable Artificial Kidney - Product Status 28
  • Table 37: Implantable Artificial Kidney - Product Description 28
  • Table 38: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 39: Hemodialysis Access Flow Restrictor Device - Product Status 29
  • Table 40: Hemodialysis Access Flow Restrictor Device - Product Description 29
  • Table 41: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 42: RenalEase - Product Status 30
  • Table 43: RenalEase - Product Description 30
  • Table 44: ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 45: Seraph 100 - Product Status 31
  • Table 46: Seraph 100 - Product Description 31
  • Table 47: ExThera Medical Corporation - Ongoing Clinical Trials Overview 32
  • Table 48: Seraph 100 - Safety and Performance Evaluation of the Seraph Microbind Affinity Blood Filter for Reducing Bacteria in Patients on Hemodialysis 33
  • Table 49: Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 50: Peritoneal Dialysis Cycler - Product Status 34
  • Table 51: Peritoneal Dialysis Cycler - Product Description 34
  • Table 52: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 53: Portable Renal Replacement System - Product Status 35
  • Table 54: Portable Renal Replacement System - Product Description 35
  • Table 55: Hemova Medical Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 56: Hemova Port Device - Product Status 36
  • Table 57: Hemova Port Device - Product Description 36
  • Table 58: Katharos, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 59: Phosfilter - Product Status 37
  • Table 60: Phosfilter - Product Description 37
  • Table 61: Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 62: HeRO Ally - Product Status 38
  • Table 63: HeRO Ally - Product Description 38
  • Table 64: Super HeRO - Product Status 39
  • Table 65: Super HeRO - Product Description 39
  • Table 66: Nephros Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 67: EndoPur 20 Endotoxin Filter Cartridge - Product Status 40
  • Table 68: EndoPur 20 Endotoxin Filter Cartridge - Product Description 40
  • Table 69: EndoPur Endotoxin 30" Filter - Product Status 41
  • Table 70: EndoPur Endotoxin 30" Filter - Product Description 41
  • Table 71: EndoPur Endotoxin 40" Filter - Product Status 41
  • Table 72: EndoPur Endotoxin 40" Filter - Product Description 42
  • Table 73: Lead-Removal Filter System - Product Status 42
  • Table 74: Lead-Removal Filter System - Product Description 42
  • Table 75: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 76: Dialysis Prosthesis Device - Product Status 43
  • Table 77: Dialysis Prosthesis Device - Product Description 43
  • Table 78: Outset Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 79: Tablo System - Home Use - Product Status 44
  • Table 80: Tablo System - Home Use - Product Description 44
  • Table 81: Outset Medical, Inc. - Ongoing Clinical Trials Overview 45
  • Table 82: Tablo System - Home Use - A Prospective Multicenter, Open Label, Non-randomized, Cross-over Study Evaluating the Use of the Tablo Hemodialysis System In-center and In-home by Subjects with End Stage Renal Disease (ESRD) who are on Stable Dialysis Regimens 46
  • Table 83: Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 84: SpiderGraft - Product Status 47
  • Table 85: SpiderGraft - Product Description 47
  • Table 86: Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 87: Phraxis InterGraft - Product Status 48
  • Table 88: Phraxis InterGraft - Product Description 48
  • Table 89: Stent Tek Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 90: ePATH System - Product Status 49
  • Table 91: ePATH System - Product Description 49
  • Table 92: Xerem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 93: Hemodialysis Implant - Product Status 50
  • Table 94: Hemodialysis Implant - Product Description 50
  • Table 95: Glossary 179

List of Figures

1.2 List of Figures

  • Figure 1: Hemodialysis Equipment - Pipeline Products by Stage of Development 10
  • Figure 2: Hemodialysis Equipment - Pipeline Products by Segment 11
  • Figure 3: Hemodialysis Equipment - Pipeline Products by Territory 12
  • Figure 4: Hemodialysis Equipment - Pipeline Products by Regulatory Path 13
  • Figure 5: Hemodialysis Equipment - Pipeline Products by Estimated Approval Date 14
  • Figure 6: Hemodialysis Equipment - Ongoing Clinical Trials 15
Back to Top